EOM Pharmaceuticals Holdings, Inc.
EOM Pharmaceuticals Holdings, Inc. (IMUC) Revenue
Annual & quarterly revenue history · segment & region breakdown
IMUC · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsEOM Pharmaceuticals Holdings, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income EOM Pharmaceuticals Holdings, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
EOM Pharmaceuticals Holdings, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from EOM Pharmaceuticals Holdings, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
IMUC revenue · 4 questionsIMUC's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · EOM Pharmaceuticals Holdings, Inc. SEC filings · GAAP · EOM Pharmaceuticals Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026